山东最权威治疗羊癫疯病的医院-【济南癫痫病医院】,NFauFwHg,淄博好的小儿羊癫疯医院,青岛治疗羊癫疯病怎么选择医院,滨州癫痫病医院,泰安小儿羊癫疯专科医院哪,济南痫病治疗治好的方式,青岛哪家医治好癫痫病的
山东最权威治疗羊癫疯病的医院滨州癫痫病多少钱能治好,青岛继发性癫痫疾病能治好吗,山东省治癫痫那家医院好,聊城哪地方癫痫病治好,济南去哪看癫痫医院好,山东小儿羊癫疯专科医院哪,泰安有治疗儿童癫痫的好医生吗
New York, Sept. 23 (Xinhua) -- A Chinese scientist was presented a prestigious U.S. award on Friday for the discovery of artemisinin, a drug therapy for malaria that has saved millions of lives across the globe, especially in the developing world. Pharmacologist Tu Youyou, 81, became the first scientist on the Chinese mainland to win Lasker Award, known as "America's Nobels" for their knack of gaining future recognition by the Nobel committee.Tu, a scientist at the China Academy of Chinese Medical Sciences in Beijing, pioneered a new approach to malaria treatment that has benefited hundreds of millions of people and promises to benefit many times more. By applying modern techniques and rigor to a heritage provided by 5000 years of Chinese traditional practitioners, she has delivered its riches into the 21st century."Not often in the history of clinical medicine can we celebrate a discovery that has eased the pain and distress of hundreds of millions of people and saved the lives of countless numbers of people, particularly children, in over 100 countries," Lucy Shapiro, a member of the award jury and professor of Stanford University, said while describing Tu' s discovery.Shapiro said the discovery, chemical identification, and validation of artemisinin, a highly effective anti-malarial drug, is largely due to the "scientific insight, vision and dogged determination" of Professor Tu and her team. She thought Professor Tu's work has provided the world with arguably the most important pharmaceutical intervention in the last half century."The discovery of artemisinin is a gift to mankind from traditional Chinese medicine," Tu said while receiving the award. "Continuous exploration and development of traditional medicine will, without doubt, bring more medicines to the world."
CANBERRA, Aug. 31 (Xinhua) -- Australia's new chief medical officer, Professor Chris Baggoley, on Wednesday said Australian should not be worried about reports that a mutant strain of the deadly bird flu virus is spreading across Asia and beyond.On Monday, the UN's Food and Agriculture Organization (FAO) said a mutant strain of the deadly avian influenza virus was spreading in Asia and issued a warning that the bird flu could spread from poultry to humans. It urged "heightened readiness and surveillance" as the mutant strain posed "unpredictable risks to human health."But Professor Baggoley, who took office on Tuesday, said Australia is well served by strict testing and customs regimes, adding that avian migration patterns also mean infected birds are highly unlikely to arrive in Australia."I don't think we should be worried," Prof Baggoley told Sky News."The country and the Australian government is certainly vigilant in relation to bird flu."Prof. Baggoley insisted the H5N1 virus remains overwhelmingly a disease of birds and it is very uncommon for humans to catch it. It is also exceedingly rare for humans to spread it among themselves.He said that even if bird flu did arrive and affected humans, Australia is ready to respond to any new and significant developments in bird flu."Australia tests migratory wild birds, looking for H5N1, and has been doing this for some years and has never found it," he said."On the human side of things, Australia has been preparing for a possible outbreak of H5N1 since 2004."We've got the laboratory capacity to diagnose influenza; we've got arrangements in place for a rapid production of an H5N1 vaccine for humans, and we've got ready access to antivirals."There have been no outbreaks of bird flu in Australia to date.The UN said the latest human death from bird flu occurred earlier this month in Cambodia, which has registered eight cases of human infection this year, all of them fatal.H5N1 has infected 565 people since it first appeared in 2003, killing 331.
MOSCOW, Aug. 30 (Xinhua) -- Russia's space agency said Tuesday that a Proton-M rocket launch failed earlier this month because of a malfunction in the upper stage.The conclusion was reached by an independent investigation commission following a series of checks, Roscosmos said in a report that was posted on its website."The commission reported that the time span reserved for the gyrostabilized platform's turn was miscalculated and narrowed, which caused the Briz-M upper stage's disorientation and the satellite's journey to a wrong orbit," the agency said.Other systems in the upper stage performed well, the agency said, adding it has lifted a ban on launches of the Proton-M carrier rockets equipped with the Briz-M upper stage.Local media reported the Briz-M, manufactured by the Khrunichev State Research and Production Space Center, has had five failures over its 12-year history of operation.On Aug. 18, a Proton-M carrier rocket failed to deliver a communications satellite into orbit. After the failure, Russia suspended launches of Proton-M rockets pending the outcome of an investigation into the failure.
JIUQUAN, Gansu, Sept. 26 (Xinhua) -- Engineers are conducting the final preparations before launching China's first space laboratory module at the end of this week at a launch center in northwest China.The unmanned Tiangong-1 module was originally scheduled to be launched into low Earth orbit between Sept. 27 and 30. However, a weather forecast showing the arrival of a cold air mass at the Jiuquan Satellite Launch Center forced the launch to be rescheduled for Sept. 29 or 30, depending on weather and other factors."This is a significant test. We've never done such a thing before," said Lu Jinrong, the launch center's chief engineer.A full ground simulation was conducted on Sunday afternoon to ensure that the module and its Long March 2F carrier rocket are prepared for the actual launch.Cui Jijun, commander-in-chief of the launch site system and director of Jiuquan Satellite Launch Center, told Xinhua that they developed a new target spacecraft for the mission and made more than 170 technical improvements to the Long March 2F, China's manned orbital carrier rocket.Engineers have also made more than 100 updates at the launch site in order to make it compatible with the Tiangong-1, Cui added.The module will conduct docking experiments after entering orbit, which is the first step in China's space station program.Cui said the launch site has an updated computer center and command monitoring system and increased ability to adapt to changes in mission conditions, as well as the resources to handle both the launch and command duties. An integrated simulation training system for space launching has also been developed for the docking mission.The mission comes just one month after the Long March 2C rocket malfunctioned and failed to send an experimental satellite into orbit. The Tiangong-1 mission was subsequently rescheduled in order to allow engineers to sort out any problems that might occur during the launch.Cui said that engineers conducted a two-month comprehensive technical check on equipment at the launch site from March to May. The safety and reliability of all the instruments have been significantly improved."[The launch site] has the full conditions to conduct the Tiangong-1 mission," said Cui.The Tiangong-1 will remain in orbit for two years. During its mission, it will dock with China's Shenzhou-8, -9 and -10 spacecrafts.Unmanned docking procedures will be an essential step toward China achieving its goal of establishing a manned space station around 2020.
CANBERRA, Aug. 31 (Xinhua) -- Australia's new chief medical officer, Professor Chris Baggoley, on Wednesday said Australian should not be worried about reports that a mutant strain of the deadly bird flu virus is spreading across Asia and beyond.On Monday, the UN's Food and Agriculture Organization (FAO) said a mutant strain of the deadly avian influenza virus was spreading in Asia and issued a warning that the bird flu could spread from poultry to humans. It urged "heightened readiness and surveillance" as the mutant strain posed "unpredictable risks to human health."But Professor Baggoley, who took office on Tuesday, said Australia is well served by strict testing and customs regimes, adding that avian migration patterns also mean infected birds are highly unlikely to arrive in Australia."I don't think we should be worried," Prof Baggoley told Sky News."The country and the Australian government is certainly vigilant in relation to bird flu."Prof. Baggoley insisted the H5N1 virus remains overwhelmingly a disease of birds and it is very uncommon for humans to catch it. It is also exceedingly rare for humans to spread it among themselves.He said that even if bird flu did arrive and affected humans, Australia is ready to respond to any new and significant developments in bird flu."Australia tests migratory wild birds, looking for H5N1, and has been doing this for some years and has never found it," he said."On the human side of things, Australia has been preparing for a possible outbreak of H5N1 since 2004."We've got the laboratory capacity to diagnose influenza; we've got arrangements in place for a rapid production of an H5N1 vaccine for humans, and we've got ready access to antivirals."There have been no outbreaks of bird flu in Australia to date.The UN said the latest human death from bird flu occurred earlier this month in Cambodia, which has registered eight cases of human infection this year, all of them fatal.H5N1 has infected 565 people since it first appeared in 2003, killing 331.